Journal Guide
International Journal of Biological Macromolecules Impact Factor 8.5: Publishing Guide
Protein and polymer engineering: structure, function, and biomedical applications
8.5
Impact Factor (2024)
~45-55%
Acceptance Rate
~90-120 days median
Time to First Decision
What Int. J. Biol. Macromol. Publishes
International Journal of Biological Macromolecules published by Elsevier covers protein science, polysaccharides, and polymers with biological applications. With JIF 8.5 and Q1 ranking in Biochemistry & Molecular Biology, IJBM emphasizes characterization of natural and engineered macromolecules with functional applications. The journal publishes research on protein structure-function, macromolecule interactions, biomedical polymers, and therapeutic applications. Critically: IJBM values macromolecules with demonstrated biological function or clear application potential. Pure structural characterization without functional context is less competitive. The journal seeks papers showing how macromolecular engineering enables therapeutic or diagnostic solutions.
- Protein structure and function: folding, domains, enzymatic activity
- Protein-protein interactions: binding mechanisms, complex formation
- Polysaccharides: structure, bioactivity, modification, therapeutic use
- Biomedical polymers: synthetic polymers, natural polymer modification, scaffolds
- Fibrillation and aggregation: amyloid formation, prevention, characterization
- Protein engineering: directed evolution, mutation effects, optimization
- Macromolecular complexes: viral particles, enzyme complexes, structural assemblies
- Therapeutic macromolecules: antibodies, peptides, protein drugs
Editor Insight
“International Journal of Biological Macromolecules publishes macromolecules with demonstrated functional or therapeutic value. We seek papers combining structural characterization with bioactivity, mechanism, and application focus. Pure structural biology without functional context is less competitive.”
What Int. J. Biol. Macromol. Editors Look For
Novel macromolecule with demonstrated biological function or therapeutic potential
Present engineered proteins, modified polymers, or natural macromolecules with clear functionality. Show bioactivity, therapeutic efficacy, or diagnostic value. Purely structural characterization without functional demonstration is less competitive.
Complete structure-function relationship characterization
Rigorously characterize macromolecule structure: X-ray crystallography, cryo-EM, NMR for proteins; spectroscopy and mass spectrometry for polymers. Show how structure enables function. Incomplete characterization reduces impact.
Mechanistic understanding of biological activity or therapeutic action
Explain how your macromolecule works at molecular level. What's the mechanism of enzyme activity or therapeutic action? How does structure drive function? Mechanistic insight strengthens papers significantly.
Biomedical application demonstration with appropriate models
For therapeutic macromolecules, demonstrate activity in cellular or animal models. Show dose-response, specificity, and therapeutic window. Clinical relevance or translational path increases impact.
Stability and manufacturability for therapeutic applications
Therapeutic macromolecules must be stable and manufacturable. Address storage stability, formulation, scalability, and cost. Unstable or impractical molecules have limited real-world impact.
Why Papers Get Rejected
These patterns appear repeatedly in manuscripts that don't make it past Int. J. Biol. Macromol.'s editorial review:
Characterizing macromolecule structure without functional validation
Detailed structural characterization alone is insufficient. IJBM expects functional relevance. Show bioactivity, enzyme activity, or therapeutic effect. Why should readers care about this structure?
Limited or inappropriate bioactivity testing
Generic cell proliferation assays without specificity testing or mechanistic validation are weak. Use appropriate models (target cells, relevant assays). Include positive and negative controls.
Protein engineering without demonstrating improved function
Showing that mutations can be made is insufficient. Demonstrate improved properties (higher activity, better specificity, enhanced stability). Mutations should yield functional improvement.
Ignoring structural basis for observed bioactivity
Papers showing activity without structural explanation of mechanism are less impactful. Connect observed function to atomic-level structure. Why does this sequence or modification enhance activity?
Overlooking aggregation, stability, or manufacturability issues
Therapeutic proteins often suffer aggregation or instability. Address potential issues explicitly. Show stability data, formulation development, manufacturability analysis.
Does your manuscript avoid these patterns?
The quick diagnostic reads your full manuscript against Int. J. Biol. Macromol.'s criteria and flags the specific issues most likely to cause rejection.
Insider Tips from Int. J. Biol. Macromol. Authors
Protein therapeutic engineering (antibodies, enzymes) has highest impact
Research on therapeutic proteins, antibody engineering, or engineered enzymes receives strong reception. Clear therapeutic potential significantly increases impact.
Cryo-EM structures revealing mechanisms are highly valued
High-resolution cryo-EM structures showing conformational changes or protein-protein interactions provide exceptional mechanistic insight. Modern cryo-EM structures are scientifically prominent.
Directed evolution and protein engineering screening
Papers demonstrating improved protein properties through directed evolution or rational engineering with selection/screening approaches are impactful and trendy.
Natural product derived macromolecules and bioactive polymers competitive
Bioactive polysaccharides, peptides, or modified natural polymers with therapeutic potential receive strong interest, especially for antimicrobial or anti-inflammatory applications.
Single-molecule studies revealing macromolecular behavior
Single-molecule fluorescence or force spectroscopy revealing conformational changes, kinetics, or interactions provide unique mechanistic insight.
The Int. J. Biol. Macromol. Submission Process
Manuscript preparation
Prep6,000-9,000 words with 6-8 figures. Include macromolecule characterization (structure, spectroscopy), bioactivity testing with appropriate controls, mechanism studies, and therapeutic/functional relevance. Supporting: structural data, bioactivity curves, stability studies.
Submission via Elsevier system
Day 0Submit at https://www.editorialmanager.com/IJBM/. Required: manuscript, figures emphasizing structure and bioactivity, cover letter highlighting functional/therapeutic significance.
Editorial assessment
1-2 weeksEditor assesses macromolecule novelty, functional significance, and characterization completeness. Papers lacking bioactivity or therapeutic context face lower priority. Moderate desk rejection ~25-35%.
Peer review
90-120 days2-3 macromolecule experts assess structure-function understanding, bioactivity data quality, and therapeutic relevance. Reviewers evaluate mechanistic claims carefully. First decision 90-120 days.
Revision and publication
Revision: 4-8 weeksRevisions often request additional functional validation, mechanism clarification, or stability data. Publication 2-4 weeks after acceptance.
Int. J. Biol. Macromol. by the Numbers
| 2024 Impact Factor | 8.2 |
| 5-Year Impact Factor | 8.6 |
| Acceptance rate | ~45-55% |
| Desk rejection rate | ~25-35% |
| Median first decision | ~105 days |
| Open access option | $2,900 USD |
| Publisher | Elsevier |
| Founded | 1983 |
Before you submit
Int. J. Biol. Macromol. accepts a small fraction of submissions. Make your attempt count.
The pre-submission diagnostic runs a live literature search, scores your manuscript section by section, and gives you a prioritized fix list calibrated to Int. J. Biol. Macromol.. ~30 minutes.
Article Types
Research Article
6,000-9,000 wordsMacromolecule characterization with bioactivity/function
Short Communication
3,000-4,500 wordsFocused macromolecule discovery with rapid publication
Review
9,000-12,000 wordsComprehensive macromolecule topic review
Landmark Int. J. Biol. Macromol. Papers
Papers that defined fields and changed science:
- Protein folding thermodynamics (Anfinsen, 1960s) - showed proteins fold to lowest energy
- Antibody engineering (1980s-1990s) - enabled monoclonal antibody therapeutics
- Directed evolution (Arnold, 1993+) - won Nobel Prize for protein engineering
- Therapeutic proteins/biologics boom (2000s-present) - proteins became major drug class
- Cryo-EM revolution (Henderson, Frank, 2010s) - enabled atomic-resolution protein structures
Preparing a Int. J. Biol. Macromol. Submission?
Get pre-submission feedback from reviewers who've published in Int. J. Biol. Macromol. and know exactly what editors look for.
Run Free Readiness ScanNeed expert depth? Human review from $1,000
Primary Fields
Related Articles
- Desk Rejection: What It Means, Why It Happens, and What to Do Next
- How to Respond to Reviewer Comments (Without Losing Your Mind)
- How to Choose the Right Journal for Your Paper (A Practical Guide)
- Pre-Submission Scientific Review: What It Costs, When It Works, and When to Skip It
Ready to submit to Int. J. Biol. Macromol.?
A desk rejection costs months. Get expert feedback before you submit, from scientists who know exactly what Int. J. Biol. Macromol. editors look for.
Avoid Desk Rejection
Get expert pre-submission review before you submit to Int. J. Biol. Macromol.. 3-7 day turnaround.
Manuscript Rejected?
Expert revision help to strengthen your manuscript and resubmit with confidence.
Reviewer Response Help
Get expert guidance crafting your response to Int. J. Biol. Macromol. reviewers.
Need field-expert depth? Human review from $1,000